Clients News • MC Services corporate website
paged,page-template-default,page,page-id-5522,paged-95,page-paged-95,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.7.0,vc_responsive




  • Allergy Therapeutics announces business development ppdate and publication date of half year results for FY 2018/2019
  • Newron Pharmaceuticals: Commercialization partner Zambon together with Valeo Pharma announce the approval of Onstryv® (safinamide) for Parkinson’s disease in Canada
  • Adocia confirms its financial calendar for 2019
  • Verona Pharma Reports Encouraging Top-Line Data from Three-Day Phase 2 Trial Evaluating Nebulized Ensifentrine (RPL554) on Top of Dual Bronchodilator Therapy for COPD Maintenance
  • Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554
  • HPS Home Power Solutions GmbH begins delivery of the first Picea customer systems
  • Medigene AG: Additional European patent granted for Medigene’s DC vaccine platform
  • Expedeon AG licenses Lightning-Link® Rapid Biotinylation technology to Cell Guidance Systems in supply agreement
  • Sterna biologicals prepares for phase IIb clinical program with GATA-3 antagonist drug candidates SB010 in asthma and SB012 in ulcerative colitis
  • AYOXXA signs research agreement in the field of ophthalmology with one of the leading pharmaceutical companies